CureVac and Gates Foundation in new vaccine project

CureVac GmbH is to start a third project with the Bill & Melinda Gates Foundation, this time to develop a vaccine to protect against respiratory syncytial virus. The partners are already working on vaccines against HIV and rotavirus.